Text Size

Observational Trial of Hepatitis C Virus Infected Patients on Calcineurin Inhibitors

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2010 by University of Wisconsin, Madison.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT00819026
First received: January 6, 2009
Last updated: February 3, 2010
Last verified: February 2010
History of Changes
  Purpose

Hepatitis C Virus is constantly evolving genetically, particularly in response to the immune system. This is an observational study to examine if immunosuppressants particularly calcineurin inhibitors taken by transplant patients in order to avoid organ rejection causes predictable changes in the genetics of this virus that might be important in order to treat it effectively.


Condition
Hepatitis C Virus

Study Type: Observational
Study Design: Time Perspective: Cross-Sectional

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Wisconsin, Madison:

Biospecimen Retention:   Samples Without DNA

viral RNA


Estimated Enrollment: 30
Study Start Date: October 2008
Estimated Study Completion Date: December 2010
Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

solid organ transplant patients

Criteria

Inclusion Criteria:

  • HCV infected on immunosuppression
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00819026

Locations
United States, Wisconsin
University of Wisconsin Recruiting
Madison, Wisconsin, United States, 53706
Contact: Rob Striker, MD/PhD     608-263-2994     rtstriker@wisc.edu    
Principal Investigator: Rob Striker, MD/PhD            
Sponsors and Collaborators
University of Wisconsin, Madison
Investigators
Principal Investigator: Robert Striker University of Wisconsin, Madison
  More Information

No publications provided

Responsible Party: Rob Striker, Assistant Professor of Medicine, university of Wisconsin
ClinicalTrials.gov Identifier: NCT00819026     History of Changes
Other Study ID Numbers: UWisHCV-1
Study First Received: January 6, 2009
Last Updated: February 3, 2010
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Hepatitis
Hepatitis A
Hepatitis C
Liver Diseases
Digestive System Diseases
Hepatitis, Viral, Human
 Virus Diseases
Enterovirus Infections
Picornaviridae Infections
RNA Virus Infections
Flaviviridae Infections

ClinicalTrials.gov processed this record on May 23, 2013